A Phase 1 Study to Assess the Safety and Tolerability of Multiple Ascending Doses of LB-P6 and LB-P8 in Healthy Participants
Conditions: Rheumatoid Arthritis; Non-Alcoholic Steatohepatitis Interventions: Drug: LB-P6, Cohort 1; Drug: LB-P8, Cohort 1; Drug: Placebo, Cohort 1; Drug: LB-P6, Cohort 2; Drug: LB-P8, Cohort 2; Drug: Placebo, Cohort 2 Sponsors: LISCure Biosciences AUS Pty LTD; Novotech (Australia) Pty Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials